Stock listing
NASDAQ:TARS Tarsus Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Tarsus Pharmaceuticals, Inc.
Follow Tarsus Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TARS
$74.85 USD +0.65 (+0.9%)
Close on Oct 30, 2026
- Day range
- $74.30 – $76.27 USDOct 30, 2026
- Volume
- 588,544 sharesOct 30, 2026
- Market cap
- $3.50B USDAt the close on Oct 30, 2026 · price × 46.79M shares outstanding
- 52-week range
- $53.89 – $91.53 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $60.80M USDMedian day 678,450 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TARS · Home | $74.85 USD | +0.65 (+0.9%) | 588,544 | $74.99 | $76.27 | $74.30 | $74.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:TARS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $74.85 | +0.65 | +0.9% | $74.99 | $76.27 | $74.30 | 588,544 | |
| $74.20 | +2.15 | +3.0% | $72.90 | $74.75 | $72.78 | 456,685 | |
| $72.05 | +1.29 | +1.8% | $69.61 | $72.44 | $69.50 | 398,079 | |
| $70.76 | +0.73 | +1.0% | $69.78 | $71.71 | $69.14 | 743,597 | |
| $70.03 | +1.83 | +2.7% | $68.37 | $71.62 | $68.36 | 728,225 | |
| $68.20 | -3.88 | -5.4% | $71.48 | $71.71 | $67.65 | 556,600 | |
| $72.08 | +1.58 | +2.2% | $70.93 | $73.11 | $69.55 | 688,700 | |
| $70.50 | -0.53 | -0.7% | $70.85 | $72.81 | $70.20 | 945,900 | |
| $71.03 | +1.53 | +2.2% | $69.54 | $72.46 | $67.93 | 899,000 | |
| $69.50 | +1.43 | +2.1% | $68.08 | $70.94 | $68.08 | 682,600 | |
| $68.07 | -2.92 | -4.1% | $70.87 | $70.87 | $67.95 | 2,871,500 | |
| $70.99 | -1.30 | -1.8% | $72.59 | $74.94 | $70.55 | 1,398,300 | |
| $72.29 | +1.47 | +2.1% | $70.57 | $73.35 | $70.03 | 1,166,700 | |
| $70.82 | -3.58 | -4.8% | $74.50 | $75.02 | $70.32 | 1,632,800 | |
| $74.40 | +1.24 | +1.7% | $73.20 | $76.64 | $72.98 | 1,463,000 | |
| $73.16 | +0.94 | +1.3% | $72.22 | $73.93 | $71.20 | 481,800 | |
| $72.22 | -1.39 | -1.9% | $73.07 | $74.52 | $70.80 | 642,100 | |
| $73.61 | -0.50 | -0.7% | $73.58 | $74.68 | $73.30 | 542,300 | |
| $74.11 | -0.345 | -0.5% | $74.48 | $75.26 | $72.94 | 432,400 | |
| $74.46 | +1.455 | +2.0% | $73.22 | $75.00 | $72.76 | 939,600 | |
| $73.00 | -2.46 | -3.3% | $75.84 | $75.84 | $72.94 | 1,205,500 | |
| $75.46 | -3.15 | -4.0% | $78.45 | $79.10 | $75.03 | 1,242,100 | |
| $78.61 | +1.92 | +2.5% | $76.76 | $78.70 | $76.32 | 1,562,900 | |
| $76.69 | -0.12 | -0.2% | $76.22 | $77.99 | $75.53 | 418,000 | |
| $76.81 | +1.12 | +1.5% | $75.83 | $76.82 | $74.66 | 1,309,600 | |
| $75.69 | -0.27 | -0.4% | $75.78 | $76.17 | $73.85 | 721,400 | |
| $75.96 | +1.67 | +2.2% | $75.33 | $77.91 | $74.44 | 598,500 | |
| $74.29 | -2.79 | -3.6% | $77.18 | $77.61 | $74.20 | 674,300 | |
| $77.08 | -0.38 | -0.5% | $77.61 | $78.59 | $76.01 | 517,000 | |
| $77.46 | -0.63 | -0.8% | $78.09 | $78.57 | $76.39 | 487,100 | |
| $78.09 | -0.94 | -1.2% | $78.67 | $79.10 | $77.33 | 711,000 | |
| $79.03 | +1.39 | +1.8% | $78.55 | $79.78 | $77.29 | 474,900 | |
| $77.64 | -0.59 | -0.8% | $78.38 | $79.75 | $77.08 | 658,800 | |
| $78.23 | -1.72 | -2.2% | $80.01 | $80.01 | $77.77 | 622,900 | |
| $79.95 | +0.64 | +0.8% | $79.69 | $80.24 | $78.40 | 689,700 | |
| $79.31 | -1.81 | -2.2% | $82.27 | $83.23 | $79.18 | 490,800 | |
| $81.12 | -1.65 | -2.0% | $80.89 | $83.34 | $80.81 | 403,300 | |
| $82.77 | -4.45 | -5.1% | $86.31 | $87.31 | $82.67 | 564,900 | |
| $87.22 | -3.56 | -3.9% | $89.67 | $90.75 | $87.01 | 1,818,500 | |
| $90.78 | +7.575 | +9.1% | $82.70 | $91.53 | $81.07 | 1,595,500 | |
| $83.21 | +0.445 | +0.5% | $82.76 | $84.50 | $81.95 | 733,700 | |
| $82.76 | +8.71 | +11.8% | $74.63 | $82.97 | $74.11 | 1,899,700 | |
| $74.05 | -0.19 | -0.3% | $73.86 | $75.08 | $73.52 | 587,200 | |
| $74.24 | +2.48 | +3.5% | $71.47 | $74.94 | $70.71 | 712,000 | |
| $71.76 | -0.16 | -0.2% | $71.19 | $72.03 | $70.73 | 615,700 | |
| $71.92 | +1.27 | +1.8% | $70.07 | $72.15 | $69.47 | 876,400 | |
| $70.65 | -0.80 | -1.1% | $71.10 | $71.15 | $69.77 | 611,500 | |
| $71.45 | -1.36 | -1.9% | $72.55 | $74.00 | $71.05 | 538,347 | |
| $72.81 | +0.11 | +0.2% | $72.88 | $73.08 | $71.77 | 414,069 | |
| $72.70 | +1.21 | +1.7% | $71.72 | $73.14 | $71.26 | 636,300 | |
| $71.49 | -1.95 | -2.7% | $72.81 | $73.42 | $70.10 | 538,100 | |
| $73.44 | +2.41 | +3.4% | $72.00 | $73.51 | $71.37 | 757,500 | |
| $71.03 | +0.415 | +0.6% | $70.73 | $71.50 | $69.67 | 628,800 | |
| $70.62 | +1.415 | +2.0% | $68.83 | $70.78 | $68.71 | 541,200 | |
| $69.20 | +0.32 | +0.5% | $68.82 | $69.70 | $67.61 | 448,300 | |
| $68.88 | -1.135 | -1.6% | $70.72 | $71.35 | $68.06 | 631,800 | |
| $70.02 | +0.555 | +0.8% | $69.89 | $70.48 | $68.34 | 1,017,400 | |
| $69.46 | +1.70 | +2.5% | $67.54 | $69.66 | $66.34 | 740,801 | |
| $67.76 | +2.97 | +4.6% | $64.79 | $67.86 | $62.85 | 947,744 | |
| $64.79 | -0.54 | -0.8% | $65.33 | $68.00 | $63.75 | 983,200 | |
| $65.33 | +4.04 | +6.6% | $57.63 | $66.24 | $57.63 | 1,649,000 | |
| $61.29 | +0.18 | +0.3% | $62.02 | $62.02 | $60.12 | 354,600 | |
| $61.11 | -0.21 | -0.3% | $61.67 | $62.19 | $60.33 | 541,900 | |
| $61.32 | +2.28 | +3.9% | $59.08 | $63.00 | $58.72 | 831,300 | |
| $59.04 | -0.50 | -0.8% | $58.85 | $59.33 | $57.32 | 637,000 | |
| $59.54 | +1.02 | +1.7% | $57.88 | $59.75 | $57.09 | 699,200 |
- Ticker
- NASDAQ:TARS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Latest earnings call · Aug 6, 2026
Tarsus Pharmaceuticals (NASDAQ:TARS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 35 slides
Calls
Upcoming
Tarsus Pharmaceuticals (NASDAQ:TARS) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 4:30 PM ET
Register
Replays
Tarsus Pharmaceuticals (NASDAQ:TARS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptTarsus Pharmaceuticals (NASDAQ:TARS) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptTarsus Pharmaceuticals (NASDAQ:TARS) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Oct 29, 2026
Closed $74.85 (+0.9%) on Oct 30, 2026
Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer
Oct 28, 2026
Closed $72.05 (+1.8%) on Oct 28, 2026
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
Sep 29, 2026
Closed $76.69 (-0.2%) on Sep 29, 2026
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
Sep 4, 2026
Closed $90.78 (+9.1%) on Sep 4, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Aug 6, 2026
Closed $65.33 (+6.6%) on Aug 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Aug 6, 2026
Closed $65.33 (+6.6%) on Aug 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Aug 6, 2026
Closed $65.33 (+6.6%) on Aug 6, 2026
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Aug 5, 2026
Closed $65.33 (+6.6%) on Aug 6, 2026
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
Jul 13, 2026
Closed $56.11 (-5.4%) on Jul 14, 2026
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
Jul 8, 2026
Closed $64.14 (-5.3%) on Jul 9, 2026
Financings
Private placement of private placement financing
Aug 6, 2026
Update: US$125M · US$56 a share · Barclays +2
Dealers: Barclays (lead), BofA Securities, William Blair
Buyers: TCGX; Bain Capital Life Sciences; Wellington Management; ADAR1 Capital Management; Sirenia Capital Management LP; RTW Investments; Vestal Point Capital
Use of proceeds: Fund clinical development and commercial activities and general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 35 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 20 slides · Aug 6, 2026
Merger or Acquisition (July 2026)
Merger or acquisition · 13 slides · Jul 8, 2026
Q1 2026 Earnings Presentation
Earnings · 14 slides · May 6, 2026
Tarsus Pharmaceuticals, Inc. on 6ix
- News releases
- 20 in the last 12 months · 124 in all · newest Oct 29, 2026 · oldest 2020
- Calls
- 12 calls with a replay · 12 with a transcript · latest Aug 6, 2026
- Decks
- 28 decks · latest September 2026
Where Tarsus Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TARS · Home listing · This page | NASDAQ | United States | USD |
| BX Swiss:TARS | BX Swiss | Switzerland | CHF |
| BOATS:TARS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Tarsus Pharmaceuticals, Inc.